Haijma SV, Van Haren N, Cahn W, Koolschijn PCM, Hulshoff Pol HE, Kahn RS. Brain volumes in schizophrenia: a meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129–38.
Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361:281–8.
Koutsouleris N, Gaser C, Jager M, Bottlender R, Frodl T, Holzinger S, et al. Structural correlates of psychopathological symptom dimensions in schizophrenia: A voxel-based morphometric study. Neuroimage. 2008;39:1600–12.
Abi-Dargham A, Horga G. The search for imaging biomarkers in psychiatric disorders. Nat Med. 2016;22:1248–55.
Article CAS PubMed Google Scholar
Insel TR, Cuthbert BN. Brain disorders? Precisely. Science. 2015;348:499–500.
Article CAS PubMed Google Scholar
Kapur S, Phillips AG, Insel TR. Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatr. 2012;17:1174–9.
Chand GB, Dwyer DB, Erus G, Sotiras A, Varol E, Srinivasan D, et al. Two distinct neuroanatomical subtypes of schizophrenia revealed using machine learning. Brain. 2020;143:1027–38.
Article PubMed PubMed Central Google Scholar
Dwyer DB, Cabral C, Kambeitz-Ilankovic L, Sanfelici R, Kambeitz J, Calhoun V, et al. Brain Subtyping Enhances The Neuroanatomical Discrimination of Schizophrenia. Schizophr Bull. 2018;44:1060–9.
Article PubMed PubMed Central Google Scholar
Kaczkurkin AN, Moore TM, Sotiras A, Xia CH, Shinohara RT, Satterthwaite TD. Approaches to Defining Common and Dissociable Neurobiological Deficits Associated With Psychopathology in Youth. Biol Psychiatry. 2020;88:51–62.
Pan Y, Pu W, Chen X, Huang X, Cai Y, Tao H, et al. Morphological Profiling of Schizophrenia: Cluster Analysis of MRI-Based Cortical Thickness Data. Schizophr Bull. 2020;46:623–32.
Article PubMed PubMed Central Google Scholar
Planchuelo-Gómez Á, Lubeiro A, Núñez-Novo P, Gomez-Pilar J, de Luis-García R, Del Valle P, et al. Identificacion of MRI-based psychosis subtypes: Replication and refinement. Prog Neuropsychopharmacol Biol Psychiatry. 2020;100:109907.
Dazzan P, Arango C, Fleischacker W, Galderisi S, Glenthøj B, Leucht S, et al. Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research. Schizophr Bull. 2015;41:574–83.
Article PubMed PubMed Central Google Scholar
Zhao Q, Cao H, Zhang W, Li S, Xiao Y, Tamminga CA, et al. A subtype of institutionalized patients with schizophrenia characterized by pronounced subcortical and cognitive deficits. Neuropsychopharmacology. 2022;47:2024–32.
Lubeiro A, Rueda C, Hernández JA, Sanz J, Sarramea F, Molina V. Identification of two clusters within schizophrenia with different structural, functional and clinical characteristics. Prog Neuropsychopharmacol Biol Psychiatry. 2016;64:79–86.
Honnorat N, Dong A, Meisenzahl-Lechner E, Koutsouleris N, Davatzikos C. Neuroanatomical heterogeneity of schizophrenia revealed by semi-supervised machine learning methods. Schizophr Res. 2019;214:43–50.
Xiao Y, Liao W, Long Z, Tao B, Zhao Q, Luo C, et al. Subtyping Schizophrenia Patients Based on Patterns of Structural Brain Alterations. Schizophr Bull. 2022;48:241–50.
Sugihara G, Oishi N, Son S, Kubota M, Takahashi H, Murai T. Distinct Patterns of Cerebral Cortical Thinning in Schizophrenia: A Neuroimaging Data-Driven Approach. Schizophr Bull. 2017;43:900–6.
Kaczkurkin AN, Sotiras A, Baller EB, Barzilay R, Calkins ME, Chand GB, et al. Neurostructural Heterogeneity in Youths With Internalizing Symptoms. Biol Psychiatry. 2020;87:473–82.
Varol E, Sotiras A, Davatzikos C. HYDRA: Revealing heterogeneity of imaging and genetic patterns through a multiple max-margin discriminative analysis framework. Neuroimage. 2016;145:346–64.
Chand GB, Singhal P, Dwyer DB, Wen J, Erus G, Doshi J, et al. Schizophrenia Imaging Signatures and Their Associations With Cognition, Psychopathology, and Genetics in the General Population. Am J Psychiatry. 2022:179:650–60.
Ayesa-Arriola R, Miguel-Corredera M, de la Foz VO, Neergaard KD, Correa-Ghisays P, Setién-Suero E, et al. Education and long-term outcomes in first episode psychosis: 10-year follow-up study of the PAFIP cohort. Psychol Med. 2021:1–12.
Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–9.
Dazzan P, Lappin JM, Heslin M, Donoghue K, Lomas B, Reininghaus U, et al. Symptom remission at 12-weeks strongly predicts long-term recovery from the first episode of psychosis. Psychol Med. 2020;50:1452–62.
Morgan C, Lappin J, Heslin M, Donoghue K, Lomas B, Reininghaus U, et al. Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study. Psychol Med. 2014;44:2713–26.
Article CAS PubMed PubMed Central Google Scholar
Morgan C, Dazzan P, Lappin J, Heslin M, Donoghue K, Fearon P, et al. Rethinking the course of psychotic disorders: modelling long-term symptom trajectories. Psychol Med. 2021;52:2641–50.
Crossley NA, Marques TR, Taylor H, Chaddock C, Dell’Acqua F, Reinders AA, et al. Connectomic correlates of response to treatment in first-episode psychosis. Brain. 2017;140:487–96.
Palaniyappan L, Marques TR, Taylor H, Handley R, Mondelli V, Bonaccorso S, et al. Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry. 2013;70:1031–40.
Fung G, Cheung C, Chen E, Lam C, Chiu C, Law CW, et al. MRI predicts remission at 1 year in first-episode schizophrenia in females with larger striato-thalamic volumes. Neuropsychobiology. 2014;69:243–8.
Chua SE, Deng Y, Chen EY, Law CW, Chiu CP, Cheung C, et al. Early striatal hypertrophy in first-episode psychosis within 3 weeks of initiating antipsychotic drug treatment. Psychol Med. 2009;39:793–800.
Article CAS PubMed Google Scholar
First MB, Spitzer RL, Gibbon M & Williams JBW. Structured clinical interview for DSM-IV-TR axis I disorders, research version, patient edition. (SCID-I/P). New York: Biometrics Research, New York State Psychiatric Institute. 2002.
Hall RC. Global assessment of functioning. A modified scale. Psychosomatics. 1995;36:267–75.
Article CAS PubMed Google Scholar
Kay SR, Opler LA, Lindenmayer J-P. The positive and negative syndrome scale (PANSS): rationale and standardisation. Br J Psychiatry. 1989;155:59–65.
Rosa P, Zanetti M, Duran F, Santos L, Menezes P, Scazufca M, et al. What determines continuing grey matter changes in first-episode schizophrenia and affective psychosis? Psychol Med. 2015;45:817–28.
Article CAS PubMed Google Scholar
Susser E, Finnerty M, Mojtabai R, Yale S, Conover S, Goetz R, et al. Reliability of the life chart schedule for assessment of the long-term course of schizophrenia. Schizophr Res. 2000;42:67–77.
Article CAS PubMed Google Scholar
Doshi J, Erus G, Ou Y, Resnick SM, Gur RC, Gur RE, et al. MUSE: MUlti-atlas region Segmentation utilizing Ensembles of registration algorithms and parameters, and locally optimal atlas selection. Neuroimage. 2016;127:186–95.
Srinivasan D, Erus G, Doshi J, Wolk DA, Shou H, Habes M, et al. A comparison of Freesurfer and multi-atlas MUSE for brain anatomy segmentation: Findings about size and age bias, and inter-scanner stability in multi-site aging studies. Neuroimage. 2020;223:117248.
Davatzikos C, Genc A, Xu D, Resnick SM. Voxel-based morphometry using the RAVENS maps: methods and validation using simulated longitudinal atrophy. Neuroimage. 2001;14:1361–9.
Article CAS PubMed Google Scholar
Varol E, Sotiras A, Davatzikos C. MIDAS: Regionally linear multivariate discriminative statistical mapping. Neuroimage. 2018;174:111–26.
Koutsouleris N, Dwyer DB, Degenhardt F, Maj C, Urquijo-Castro MF, Sanfelici R, et al. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression. JAMA Psychiatry. 2021;78:195–209.
Gómez-Verdejo V, Parrado-Hernández E, Tohka J. Sign-consistency based variable importance for machine learning in brain imaging. Neuroinformatics. 2019;17:593–609.
Article PubMed PubMed Central Google Scholar
Radua J, Borgwardt S, Crescini A, Mataix-Cols D, Meyer-Lindenberg A, McGuire P, et al. Multimodal meta-analysis of structural and functional brain changes in first episode psychosis and the effects of antipsychotic medication. Neurosci Biobehav Rev. 2012;36:2325–33.
Article CAS PubMed Google Scholar
van Erp TGM, Walton E, Hibar DP, Schmaal L, Jiang W, Glahn DC, et al. Cortical Brain Abnormalities in 4474 Individuals With Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics Through Meta Analysis (ENIGMA) Consortium. Biol Psychiatry. 2018;84:644–54.
留言 (0)